1 August 2006
SMITHS Medical, part of the global engineering business Smiths Group, announced today it has launched a new range of advanced embryo replacement catheters in response to the changing needs of fertility specialists.
The Sure-Pro and Sure-Pro Ultra catheters, which will be used for in-vitro fertilisation procedures, are the result of research by Smiths Medical into the changing needs of its customers.
The new range was showcased in June at National Infertility Day - a patient awareness event in London. Patients said they liked the idea that they could see their embryos being released thanks to the Sure-Pro Ultra catheter, which is visible under ultrasound.
Smiths Medical is the global market leader in embryo transfer products consistently striving to innovate its range and offer advanced fertility solutions to its customers.
ENDS
Related articles
John Crane signs five-year contract to support major oil company’s Canada complex
Read our latest company news as John Crane signs a 5-year contract with a major hydrocarbon processing complex
Find out more
John Crane awarded major 5-year Dry Gas Seal repair contract from KPO
John Crane, a global leader in rotating equipment solutions and energy transition technologies and services, and a business of Smiths Group plc, has been awarded a significant contract from Karachaganak Petroleum Operating B.V. (KPO) one of the major oil and gas operators based in Kazakhstan.
Find out more
Smiths Interconnect launches new technology to reduce power loss in industrial batteries
Innovative, environmentally friendly product provides up to 90% more energy transfer than existing offering
Find out more
